title: Reply to: Letter to the editor "Impact of the CYP2C19*17 polymorphism on the pharmacokinetics and pharmacodynamics of proton pump inhibitors".
authors: Fen
authors: F
authors: Jiang
authors: Jae-Gook
authors: JG
authors: Shin
mesh_terms: D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D001562:Benzimidazoles / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008297:Male; D054328:Proton Pump Inhibitors / Q000493:pharmacokinetics*; D013450:Sulfones / Q000493:pharmacokinetics*; D013454:Sulfoxides / Q000493:pharmacokinetics*
chemical_list: D001562:Benzimidazoles; D054328:Proton Pump Inhibitors; D013450:Sulfones; D013454:Sulfoxides; D001189:Aryl Hydrocarbon Hydroxylases